新生血管性年龄相关性黄斑变性十年纤维化发生率及其发展危险因素
回顾性多中心队列纳入两个意大利转诊中心225只接受抗VEGF治疗的初治新生血管性年龄相关性黄斑变性眼,随访10年。纤维化累积发生率为62.7%,发生率为每100人年8.9例。基线视力更差、中心子区厚度变化更大、黄斑下出血及注射次数更多与纤维化独立相关。
要点
- 10年纤维化累积发生率为62.7%,发生率为每100人年8.9例。
- 纤维化独立相关因素包括中心子区厚度变化更大(P<.001)、黄斑下出血(P=.008)、注射次数更多(P=.01)及基线视力更差(P=.03)。
- 10年视力下降16.4个ETDRS字母,混合型及视网膜下纤维化眼视力下降更显著(P<.001)。
核心结论
- 在大型新生血管性年龄相关性黄斑变性队列中,10年纤维化累积发生率为62.7%。
- 纤维化在频繁复发和基线视力较低时更常见,其发生对最终视力有显著影响。
- 作者认为这支持新生血管性年龄相关性黄斑变性患者应尽早接受主动治疗方案。
研究设计与样本
- 回顾性、多中心队列研究,纳入225只初治新生血管性年龄相关性黄斑变性眼。
- 眼接受玻璃体腔内抗血管内皮生长因子治疗,在两个意大利转诊中心随访10年。
- 基线和每年审查人口学与临床数据;纤维化发生通过临床评估照片、眼底描述或荧光素血管造影确定。
- 纤维化光学相干断层扫描由外部阅片中心检查并分级为视网膜色素上皮下、混合型或视网膜下。
主要发现
- 基线平均年龄为72.1±6.9岁。
- 纤维化发生率为每100人年8.9例,10年累积发生率为62.7%。
- 纤维化病变位于视网膜色素上皮下者占46.1%,混合型占29.8%,视网膜下占22.7%。
- 与纤维化独立相关的因素包括:中心子区厚度变化更大(P<.001)、黄斑下出血(P=.008)、注射次数更多(P=.01)、基线视力更差(P=.03)。
- 2型黄斑新生血管与混合型和视网膜下纤维化显著相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report the incidence and risk factors for fibrosis at 10 years in a large cohort of persons with neovascular age-related macular degeneration (nAMD). DESIGN: Retrospective, multicenter, cohort study. METHODS: We included 225 naive nAMD eyes that underwent intravitreal anti-vascular endothelial growth factor treatment over 10 years of follow-up at two Italian referral centers. Demographic and clinical data were reviewed at baseline and on an annual basis. Onset of fibrosis was defined by clinically assessing photographs, fundus descriptions, or fluorescein angiograms. Optical coherence tomography (OCT) scans of fibrosis were inspected by an external reading center and graded as subretinal pigment epithelium (RPE), mixed, or subretinal. RESULTS: The mean age at baseline was of 72.1 ± 6.9 years. The incidence rate of fibrosis was estimated to be 8.9 per 100 person-years, with a cumulative incidence of 62.7% at 10 years. Fibrotic lesions were sub-RPE in 46.1%, mixed in 29.8%, and subretinal in 22.7%. Independent factors associated with fibrosis included the following: larger central subfield thickness variation (P < .001), submacular hemorrhages (P = .008), higher number of injections (P = .01), and worse baseline visual acuity (VA) (P = .03). Type 2 macular neovascularization was significantly associated with mixed and subretinal fibrosis. VA significantly declined over 10 years (-16.4 Early Treatment Diabetic Retinopathy Study [ETDRS] letters), particularly in eyes with mixed and subretinal fibrosis (P < .001). CONCLUSIONS: We identified a 62.7% cumulative incidence of fibrosis in a large nAMD cohort at 10 years. Fibrosis was more common with frequent reactivations and lower baseline VA; its onset had a significant impact on final VA. This supports the hypothesis that nAMD patients should be promptly treated with proactive regimens.
引用
- Romano F, Cozzi E, Airaldi M, et al. Ten-Year Incidence of Fibrosis and Risk Factors for Its Development in Neovascular Age-Related Macular Degeneration. Am J Ophthalmol. 2023. PMID: 37030492. doi:10.1016/j.ajo.2023.03.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。